These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 38246112)

  • 1. Genomic and epidemiological insight of an outbreak of carbapenemase-producing Enterobacterales in a Portuguese hospital with the emergence of the new KPC-124.
    Manageiro V; Cano M; Furtado C; Iglesias C; Reis L; Vieira P; Teixeira A; Martins C; Veloso I; Machado J; Paiva JA; Caniça M
    J Infect Public Health; 2024 Mar; 17(3):386-395. PubMed ID: 38246112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outbreak of Klebsiella pneumoniae ST11 Resistant To Ceftazidime-Avibactam Producing KPC-31 and the Novel Variant KPC-115 during COVID-19 Pandemic in Argentina.
    Nicola F; Cejas D; González-Espinosa F; Relloso S; Herrera F; Bonvehí P; Smayevsky J; Figueroa-Espinosa R; Gutkind G; Radice M
    Microbiol Spectr; 2022 Dec; 10(6):e0373322. PubMed ID: 36445147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deciphering variable resistance to novel carbapenem-based β-lactamase inhibitor combinations in a multi-clonal outbreak caused by Klebsiella pneumoniae carbapenemase (KPC)-producing Klebsiella pneumoniae resistant to ceftazidime/avibactam.
    Di Pilato V; Principe L; Andriani L; Aiezza N; Coppi M; Ricci S; Giani T; Luzzaro F; Rossolini GM
    Clin Microbiol Infect; 2023 Apr; 29(4):537.e1-537.e8. PubMed ID: 36414199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emergence of Ceftazidime-Avibactam Resistance Due to Plasmid-Borne
    Shields RK; Chen L; Cheng S; Chavda KD; Press EG; Snyder A; Pandey R; Doi Y; Kreiswirth BN; Nguyen MH; Clancy CJ
    Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 28031201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Ceftazidime-Avibactam Treatment in the Emergence of Novel KPC Variants in the ST307-Klebsiella pneumoniae High-Risk Clone and Consequences for Their Routine Detection.
    Hernández-García M; Castillo-Polo JA; Cordero DG; Pérez-Viso B; García-Castillo M; Saez de la Fuente J; Morosini MI; Cantón R; Ruiz-Garbajosa P
    J Clin Microbiol; 2022 Mar; 60(3):e0224521. PubMed ID: 35107303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous Hospital Outbreaks of New Delhi Metallo-β-Lactamase-Producing
    Lo S; Lolom I; Goldstein V; Petitjean M; Rondinaud E; Bunel-Gourdy V; Tran Dinh A; Wicky PH; Ruppé E; d'Humières C; Lucet JC; Armand-Lefèvre L
    Microbiol Spectr; 2022 Apr; 10(2):e0228721. PubMed ID: 35311539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resistome and virulome accretion in an NDM-1-producing ST147 sublineage of Klebsiella pneumoniae associated with an outbreak in Tuscany, Italy: a genotypic and phenotypic characterisation.
    Di Pilato V; Henrici De Angelis L; Aiezza N; Baccani I; Niccolai C; Parisio EM; Giordano C; Camarlinghi G; Barnini S; Forni S; Righi L; Mechi MT; Giani T; Antonelli A; Rossolini GM;
    Lancet Microbe; 2022 Mar; 3(3):e224-e234. PubMed ID: 35544076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outbreak of IncX8 Plasmid-Mediated KPC-3-Producing Enterobacterales Infection, China.
    Chen L; Ai W; Zhou Y; Wu C; Guo Y; Wu X; Wang B; Rao L; Xu Y; Zhang J; Chen L; Yu F
    Emerg Infect Dis; 2022 Jul; 28(7):1421-1430. PubMed ID: 35731165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bloodstream infection caused by KPC-producing Klebsiella pneumoniae resistant to ceftazidime/avibactam: epidemiology and genomic characterization.
    Gaibani P; Re MC; Campoli C; Viale PL; Ambretti S
    Clin Microbiol Infect; 2020 Apr; 26(4):516.e1-516.e4. PubMed ID: 31740422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular characterization of carbapenemase-producing Enterobacterales in a tertiary hospital in Lima, Peru.
    Cuicapuza D; Loyola S; Velásquez J; Fernández N; Llanos C; Ruiz J; Tsukayama P; Tamariz J
    Microbiol Spectr; 2024 Feb; 12(2):e0250323. PubMed ID: 38193666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of KPC-112 from an ST15 Klebsiella pneumoniae Strain Conferring Resistance to Ceftazidime-Avibactam.
    Shen S; Tang C; Ding L; Han R; Yin D; Yang W; Guo Y; Hu F
    mSphere; 2022 Dec; 7(6):e0048722. PubMed ID: 36374086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colonization by ceftazidime/avibactam-resistant KPC-producing Klebsiella pneumoniae following therapy in critically ill patients.
    Gaibani P; Bovo F; Bussini L; Bartoletti M; Lazzarotto T; Viale P; Pea F; Ambretti S
    Clin Microbiol Infect; 2023 May; 29(5):654.e1-654.e4. PubMed ID: 36716999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Covert dissemination of carbapenemase-producing Klebsiella pneumoniae (KPC) in a successfully controlled outbreak: long- and short-read whole-genome sequencing demonstrate multiple genetic modes of transmission.
    Martin J; Phan HTT; Findlay J; Stoesser N; Pankhurst L; Navickaite I; De Maio N; Eyre DW; Toogood G; Orsi NM; Kirby A; Young N; Turton JF; Hill RLR; Hopkins KL; Woodford N; Peto TEA; Walker AS; Crook DW; Wilcox MH
    J Antimicrob Chemother; 2017 Nov; 72(11):3025-3034. PubMed ID: 28961793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful control of the first OXA-48 and/or NDM carbapenemase-producing Klebsiella pneumoniae outbreak in Slovenia 2014-2016.
    Pirš M; Cerar Kišek T; Križan Hergouth V; Seme K; Mueller Premru M; Jeverica S; Logar M; Mrvič T; Žnidaršič B; Jordan Markočič O; Lejko Zupanc T
    J Hosp Infect; 2019 Feb; 101(2):142-149. PubMed ID: 30399389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology and risk factors of rectal colonization of carbapenemase-producing Enterobacteriaceae among high-risk patients from ICU and HSCT wards in a university hospital.
    Yan L; Sun J; Xu X; Huang S
    Antimicrob Resist Infect Control; 2020 Sep; 9(1):155. PubMed ID: 32967718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamic evolution of imipenem/relebactam resistance in a KPC-producing Klebsiella pneumoniae from a single patient during ceftazidime/avibactam-based treatments.
    Gaibani P; Bovo F; Bussini L; Lazzarotto T; Amadesi S; Bartoletti M; Viale P; Ambretti S
    J Antimicrob Chemother; 2022 May; 77(6):1570-1577. PubMed ID: 35373297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversal of carbapenemase-producing Klebsiella pneumoniae epidemiology from blaKPC- to blaVIM-harbouring isolates in a Greek ICU after introduction of ceftazidime/avibactam.
    Papadimitriou-Olivgeris M; Bartzavali C; Lambropoulou A; Solomou A; Tsiata E; Anastassiou ED; Fligou F; Marangos M; Spiliopoulou I; Christofidou M
    J Antimicrob Chemother; 2019 Jul; 74(7):2051-2054. PubMed ID: 31002313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An Outbreak of KPC-Producing
    Song JE; Jeong H; Lim YS; Ha EJ; Jung IY; Jeong W; Choi H; Jeong SJ; Ku NS; Park ES; Yong D; Lee K; Kim JM; Choi JY
    Microb Drug Resist; 2019 Dec; 25(10):1475-1483. PubMed ID: 31334673
    [No Abstract]   [Full Text] [Related]  

  • 19. Increased Expression and Amplification of
    Li X; Zhang J; Yang C; Li J; Wang J; Huang W; Zeng L; Liang X; Long W; Zhang X
    Microbiol Spectr; 2022 Aug; 10(4):e0095522. PubMed ID: 35900090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emergence of ceftazidime/avibactam resistance in KPC-3-producing Klebsiella pneumoniae in vivo.
    Göttig S; Frank D; Mungo E; Nolte A; Hogardt M; Besier S; Wichelhaus TA
    J Antimicrob Chemother; 2019 Nov; 74(11):3211-3216. PubMed ID: 31365094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.